Abstract
Background:Biologic disease modifying anti-rheumatic drugs (bDMARDs) are known to be effective in controlling disease activity and reducing radiographic progression in patients with rheumatoid arthritis (RA) who have failed methotrexate (MTX)....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
